Randomized clinical trial of local infiltration plus patient-controlled opiate analgesia vs. epidural analgesia following liver resection surgery  by Revie, Erica J. et al.
ORIGINAL ARTICLE
Randomized clinical trial of local infiltration plus
patient-controlled opiate analgesia vs. epidural
analgesia following liver resection surgery
Erica J. Revie1, Dermot W. McKeown2, John A. Wilson2, O. James Garden1 & Stephen J. Wigmore1
1Department of Clinical Surgery, University of Edinburgh, Edinburgh, UK and 2Department of Anaesthesia, Critical Care and Pain Medicine, Royal Infirmary
of Edinburgh, Edinburgh, UK
Abstracthpb_490 611..618
Objectives: Epidural analgesia is recommended for the provision of analgesia following major abdomi-
nal surgery. Continuous local anaesthetic wound infiltration may be an effective alternative. A prospective
randomized trial was undertaken to compare these two methods following open liver resection. The
primary outcome was length of time required to fulfil criteria for discharge from hospital.
Methods: Patients undergoing open liver resection were randomized to receive either epidural (EP
group) or local anaesthetic wound infiltration plus patient-controlled opiate analgesia (WI group) for the
first 2 days postoperatively. All other care followed a standardized enhanced recovery protocol. Time to
fulfil discharge criteria, pain scores, physical activity measurements and complications were recorded.
Results: Between August 2009 and July 2010, 65 patients were randomized to EP (n = 32) or WI (n = 33).
The mean time required to fulfil discharge criteria was 4.5 days (range: 2.5–63.5 days) in the WI group and
6.0 days (range: 3.0–42.5 days) in the EP group (P = 0.044). During the first 48 h following surgery, pain
scores were significantly lower in the EP group both at rest and on movement. Resting pain scores within
both groups were rated as mild (range: 0–3). There was no significant difference between the groups in
time to first mobilization or overall complication rate (48.5% in the WI group vs. 58.1% in the EP group;
P = 0.443).
Conclusions: Local anaesthetic wound infiltration combined with patient-controlled opiate analgesia
reduces the length of time required to fulfil criteria for discharge from hospital compared with epidural
analgesia following open liver resection. Epidural analgesia provides superior analgesia, but does not
confer benefits in terms of faster mobilization or recovery.
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Introduction
The provision of adequate pain relief following open liver
resection is vital to minimize patient distress, allow effective
mobilization and prevent complications. Ideally, analgesia
should be safe, easy to administer and have few side-effects. Unfor-
tunately, this can be difficult to achieve and some degree of com-
promise is usually required.
Intravenous opiate patient-controlled analgesia (PCA) is
associated with good patient satisfaction and is straightforward
to administer and monitor.1 However, the side-effects of opiate
analgesia may prove troublesome in attempts to achieve adequate
analgesia following major surgery.
Data contained in this paper were presented at the International Surgical
Congress of the Association of Surgeons of Great Britain and Ireland, 11–13
May 2011, Bournemouth.
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An early meta-analysis reported the widespread benefits of epi-
dural analgesia over opioid analgesia in terms of mortality and
major morbidity.2 Two subsequent large randomized trials failed
to demonstrate many of these reported benefits, but did show
improved analgesia and a reduced incidence of postoperative res-
piratory failure, specifically in high-risk patients undergoing high-
risk procedures.3,4 Improved pain relief and avoidance of opiates
are likely to contribute to the beneficial effects on postoperative
ileus seen with epidural analgesia.5 Epidural analgesia remains
popular, is considered by many to represent the reference standard
in major abdominal surgery, and is advocated in enhanced recov-
ery programmes.
However, it is widely recognized that the epidural technique is
not universally successful and that inadequate analgesia is experi-
enced by 20–30% of patients.6,7 The management of poorly func-
tioning epidurals is time-consuming and may be particularly
difficult to achieve out of hours when the time of appropriately
trained staff is subject to increased demands. Epidural-associated
hypotension is a frequently encountered problem. Appropriate
management includes i.v. fluid administration and the use of vaso-
active drugs. However, i.v. fluid administration may be significant
and may result in a patient receiving an excessive volume of fluid.8
Infrequent but potentially devastating complications such as
epidural haematoma or abscess formation must always be consid-
ered.9 In major hepatic resection, in which some degree of
postoperative coagulopathy is frequently encountered, this point
merits special consideration.10 There is little evidence to support
or refute the theory of an increased risk for epidural haematoma
following liver resection as this complication remains extremely
rare. However, this issue is an area of ongoing concern for some11
and although epidural analgesia remains popular in the UK fol-
lowing liver resection, it is not universally employed worldwide.
Continuous infiltration of local anaesthetic using wound cath-
eters placed in the abdominal wall has recently emerged as an
alternative means of providing postoperative analgesia. An initial
meta-analysis of randomized trials involving local anaesthetic
wound catheters reported mixed results.12 It has become clear that
catheter placement is key to the success of the technique. Recent
studies in open nephrectomy and colorectal resection have dem-
onstrated that the placement of catheters in the appropriate
muscle layers can achieve a significant reduction in requirements
for additional opiates.13,14 Use of this technique in liver resection
was first described by Basu et al.15 Chan et al. subsequently
confirmed its efficacy in this context in a randomized controlled
trial (RCT).16 What remains to be investigated is how this analge-
sic technique compares with the current reference standard, epi-
dural analgesia.
This study aimed to evaluate the use of continuous infiltration
of local anaesthetic as part of a multimodal analgesic regimen, as
an alternative to epidural analgesia, within an enhanced recovery
programme following open liver resection.
Materials and methods
Ethical approval for the study was obtained from the Lothian
Research Ethics Committee. Potential participants were identified
through the hepatopancreaticobiliary (HPB) multidisciplinary
team meeting at the Royal Infirmary of Edinburgh and were
approached in the outpatient department.All patients undergoing
open liver resection for benign or malignant conditions were
considered for inclusion. Exclusion criteria are listed in Fig. 1. All
participants gave written consent prior to inclusion. Participants
were counselled preoperatively on the daily targets that would be
set postoperatively and the anticipated timeline for their recovery.
Baseline characteristics recorded included age, gender, comorbidi-
ties and indications for surgery.
A sample size calculation was performed using local historic
data on length of hospital stay following liver resection and pilot
data on the use of local anaesthetic wound infiltration in this
setting. The median length of hospital stay was 6 days. Using
log-transformed data, the mean length of stay was calculated as
0.819 (standard deviation 0.204). To demonstrate a reduction in
length of stay of 0.153 (approximately 1.5 days), with a level of
statistical significance of 0.05 and a power of 0.85, it was calculated
that 32 patients would be required in each arm of the study. The
Royal Infirmary of Edinburgh provides a hepatobiliary service
to patients who live a significant distance from the hospital and
length of stay can be influenced by factors such as transport avail-
ability. Time required to fulfil criteria for discharge from hospital
was therefore used as the primary endpoint of the study in order to
reflect functional recovery more accurately than actual length of
hospital stay.
Contraindication to either epidural or wound catheter techniques •
• Inability to give written, informed consent 
• Dementia or neurological impairment 
• Pre-existing condition limiting mobility 
• Underlying cirrhotic liver disease 
• Jaundice (bilirubin > 50 µmol/l) 
• Liver resection combined with secondary surgical procedure 
• Body mass index of < 18 or > 40 
• Pregnancy or lactation 
Figure 1 Exclusion criteria
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Block randomization, stratified by age (<60 years or
60 years), was performed using sealed envelopes and was under-
taken by anaesthesia staff prior to the arrival of the patient in the
anaesthesia room. Patients were randomized to receive either
local anaesthetic infiltration via wound catheters plus PCA (WI
group), or epidural analgesia (EP group). A single-blind design
was employed. Patients in both arms of the study received 2 mg
midazolam on arrival in the anaesthesia room. Patients in the
EP group underwent mid-thoracic epidural catheter insertion at
approximately T7–8. A test dose of 4 ml 2% lignocaine was given,
followed by infusion of 0.1% bupivacaine and 2 mcg/ml fentanyl
commenced at 7–10 ml/h. Patients in the WI group had a sham
epidural fixed to the back with standardized dressings, connected
to a non-active epidural pump.
Antibiotic and thromboprophylaxis were given pre-procedure.
Induction of anaesthesia in both groups followed a standardized
protocol, using 1–2 mcg/kg fentanyl, 0.1–0.15 mg/kg vecuronium,
and propofol. Patients in the WI group also received a loading
dose of 5–10 mg i.v. morphine and further morphine as deemed
appropriate by anaesthesia staff throughout the surgical proce-
dure. Isoflurane or desflurane was administered for maintenance
of anaesthesia. Intravenous fluids were administered at 100 ml/h
maintenance (0.18% sodium chloride/4% dextrose) along with
colloid boluses to replace blood loss. All patients received anti-
emetic ondansetron 4 mg i.v. before the reversal of the neuromus-
cular blockade and termination of anaesthesia.
Liver resectionwas performed through a right subcostal incision
extended upwards to the midline or across the midline. Extent of
resection, requirement for hepaticojejunostomy, operating time,
estimated blood loss, wound length and intraoperative complica-
tions were all noted. Nasogastric tubes were not placed routinely;
when nasogastric tubes were placed intraoperatively, they were
removed before the end of the surgical procedure. Surgical and
anaesthetic details were recorded on a standardized data collection
form.
At the end of the surgical procedure, dual wound catheters
(On-Q® SilverSoaker™; B. BraunMedical Ltd, Sheffield,UK),with
an active length of 12.5 cm,were placed in patients in theWI group
under direct vision in the deep muscle layers, between the trans-
versus abdominus and internal oblique laterally, and in the poste-
rior rectus sheathmedially.Thesewere flushedwith a total of 20 ml
0.25% levobupivacaine and connected to an elastomeric pump
(On-Q® PainBuster®; B. Braun Medical Ltd). The pump delivered
0.375% levobupivacaine at 4 ml/h over a 48-h period. Patients in
theWI group also received an opiate PCAdevice, butwere unaware
of which randomization group this related to. In patients in the
EP group, sham wound catheters were attached to the anterior
abdominal wall in standardized positions using opaque dressings
and were connected to a non-active elastomeric pump.All patients
received paracetamol (acetaminophen) 1 g four times per day
throughout the postoperative period, except those in whom there
was concern regarding the size or quality of the liver remnant; this
decision was left to the discretion of the operating surgeon.
In the postoperative period, patients in both arms of the study
followed a standardized enhanced recovery protocol, modified
fromHendry et al.17 (Fig. 2). This set targets for the resumption of
normal dietary intake, the removal of catheters and lines, and
mobilization. In the study institution, pain scores are measured
hourly in the high dependency unit (HDU), using a 3-point scale
(mild, moderate, severe). For the purposes of this study, a more
sensitive numerical rating scale of 0–10 was employed, and for
practical reasons pain scores were measured at 2 h, 6 h and 12 h
postoperatively, plus once daily at 09.00 hours for the following
6 days. Nausea and sedation scores were also recorded at these
time-points. In the initial postoperative period, patients were
reviewed by the acute pain service (APS) and their randomized
analgesic method optimized. Changes to epidural infusion rate
and boluses were made as directed by the APS and were not
patient-controlled. A standardized protocol for the management
of poorly functioning epidurals was followed. Persistently high
pain scores after a defined number of epidural boluses within a
specified time period were considered to indicate the failure of the
epidural technique and to indicate that a dislodged epidural cath-
eter should be replaced (if it was safe and practical to do so) or
that the patient should be converted to i.v. opiate PCA. Epidural-
associated hypotension was managed prophylactically with 30 mg
oral ephedrine, administered prior to mobilization, and persistent
epidural-associated hypotension was managed with a continuous
i.v. infusion of vasoactive drugs as required.
A standardized oral analgesic regimen was commenced on the
morning of the second postoperative day in both study arms. This
comprised paracetamol 1 g four times per day, ibuprofen 400 mg
three times per day (unless contraindicated, in which case trama-
dol 100 mg four times per day was used), plus oxycodone 10 mg as
required for breakthrough pain relief.
Patient mobility was recorded using an activPAL™ physical
activity logger (PAL Technologies Ltd, Glasgow, UK).18 This
monitor was worn on the right thigh from entry to the recovery
room until discharge from hospital, or for the first 7 days, which-
ever was sooner. This device recorded continuous information
on the patient’s position such as whether the patient was lying,
standing or stepping.
Twice daily, patients were assessed against a set of criteria for
discharge initially from the HDU and latterly from hospital
(Fig. 3). The criteria for discharge from hospital assessed func-
tional recovery and have been used previously in work published
from this institution.17 In addition to five key discharge criteria,
willingness to go home was included as a measure of a patient’s
satisfaction with his or her recovery. Both the length of time
required to fulfil discharge criteria and actual length of stay were
noted. Complications were recorded and graded using an estab-
lished classification system.19
All data were entered into a database using Microsoft Excel
2004 (Microsoft Corp., Redmond,WA, USA). Data were analysed
on an intention-to-treat basis, using spssVersion 15.0 (SPSS, Inc.,
Chicago, IL, USA). Data on time required to fulfil criteria for
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discharge were normalized by taking the reciprocal, and an inde-
pendent sample t-test was performed. Pearson’s chi-squared and
Fisher’s exact tests were also used as appropriate. Pain scores were
analysed using repeated-measures analysis of variance (anova),
controlling for age, gender, body mass index (BMI) and wound
length. Data are presented as medians and ranges, unless stated
otherwise.
Results
Between August 2009 and July 2010, 116 patients were scheduled
to undergo liver resection at the Royal Infirmary of Edinburgh. Of
these, 26 patients were excluded and a further 25 declined to
participate in the study for the reasons shown in Fig. 4. A total of
65 patients were randomized to wound infiltration plus PCA (WI
Preoperatively 
• The patient is given information about postoperative targets and anticipated recovery times in clinic 
• Normal diet until midnight the night before surgery 
Day of surgery 
• No pre-medication except in very anxious patients 
• Warmed i.v. fluids intraoperatively and use of an upper and lower body air warming device 
• Maintenance of anaesthesia with sevoflurane or desflurane. No nitrous oxide 
• No routine use of nasogastric tubes. If placed intraoperatively, tubes were removed at the end of the surgical procedure 
• No routine drainage of the peritoneal cavity 
• Routine antiemetic (ondansetron 4 mg) prior to reversal of anaesthesia 
• Re-start of oral intake on the evening of surgery 
• Maintenance of i.v. fluids 4% dextrose/0.18% saline at 80 ml/h 
• Mobilize to chair for 2 h on the evening of surgery 
• Prophylactic oral ephedrine 30 mg prior to mobilization in epidural patients 
Postoperative day 1 
• Remove arterial and central lines if not clinically required 
• Resume normal diet and discontinue i.v. fluids if oral intake is > 1 l 
• Standard thromboprophylaxis (enoxaparin 20 mg plus elasticated compression stockings) 
• Mobilize out of bed for ≥ 6 h 
• Assess criteria for discharge from the high dependency unit twice daily 
Postoperative day 2 
• Continue normal diet 
Convert to oral analgesic regimen •
• Remove epidural catheter if international normalized ratio (INR) is < 1.5 
• Remove urinary catheter unless clinically required 
• Mobilize out of bed for ≥ 8 h 
• Assess criteria for discharge from the high dependency unit twice daily 
Postoperative day 3 onwards 
• Continue normal diet and oral analgesia 
• Increase mobilization 
• Assess criteria for discharge from hospital twice daily 
Figure 2 Enhanced recovery care plan followed by both groups following open liver resection
• Adequate pain control on oral analgesia 
• Eating and drinking with no requirement for i.v. fluids in previous 24 h 
• Independently mobile (can mobilize independently to go to and from the toilet) 
• Able to perform activities of daily living (washing, dressing) without help from nursing staff 
• Blood tests return to normal range 
• Patient willing to go home 
Figure 3 Criteria for discharge from hospital following open liver resection
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group, n = 33) or to epidural analgesia (EP group, n = 32). One
patient in the EP group experienced a cardiac event after the
induction of anaesthesia and did not proceed to surgery; this
patient was therefore removed from the analysis.
Analysis of baseline characteristics demonstrated that the two
groups were well matched in most respects, although BMI was
significantly greater in the WI group (Table 1). The predominant
indication for liver resection was colorectal metastases and,
accordingly, approximately 60% of patients in each group had
undergone previous laparotomy. One patient in each group was
taking regular opiate analgesia for pain prior to liver resection.
Analysis of intraoperative details demonstrated that a significantly
greater number of major resections (three or more segments)
were performed in the WI group; this corresponded with a sig-
nificantly greater operating time in this group (Table 1). Wound
length was also significantly greater in the WI group.
The primary outcome was length of time required to fulfil
criteria for discharge from hospital. The median length of time
was 4.5 days (range: 2.5–63.5 days) in the WI group and 6.0 days
(range: 3.0–42.5 days) in the EP group (P = 0.044). Discharge was
delayed in one patient in the WI group as a result of abnormal
coagulation and one patient in the EP group as a result of throm-
bocytopenia. After meeting the five key criteria for discharge from
hospital, three patients in the EP group and five patients in theWI
group were unwilling to go home on that day. However, all these
patients were willing to be discharged within the following 24 h.
The median length of time required to fulfil criteria for discharge
from the HDU was 1.5 days (range: 0–4.5 days) in the WI group
and 1.5 days (range: 0.5–4.5 days) in the EP group (P = 0.002).
Pain scores were lower in the EP group both at rest and on
movement (Fig. 5). The median pain scores at rest in both groups
were scored as mild (0–3 on a numerical rating scale).As expected,
total narcotic use was greater in the WI group as opiate PCA was
routine in this group but not in the EP group.
There was no significant difference between the groups in the
timing of first mobilization. However, the number of steps taken
in the first 48 h after surgery was significantly greater in the WI
group [WI group: 6 steps (range: 0–560 steps); EP group: 2 steps
(range: 0–570 steps); P = 0.040].
One death occurred in each group. There was no significant
difference between the groups in overall complication rate or
grade of complications (Table 2). There were no instances of epi-
dural haematoma or abscess formation in either group.
Discussion
This study assessed the influence of postoperative analgesic
method on length of time to fulfil criteria for discharge from
hospital following open liver resection within an enhanced recov-
ery protocol.
It was hypothesized that increased freedom to mobilize and
a reduced requirement for intensive cardiovascular monitoring
would allow the WI group to fulfil criteria for discharge from the
HDU more quickly and to reach fitness for discharge from hos-
pital in a shorter length of time than the EP group. The length
of time required to fulfil criteria for discharge from hospital
was indeed significantly shorter in the WI group. This occurred
despite a significantly greater number of major resections in this
group. A significant difference was also observed between the
treatment groups in the time required to fulfil criteria for dis-
charge from the HDU, in favour of the WI group.
In the present institution, patients with epidural analgesia
are managed within a level 2 (HDU) environment as there is
no facility for level 1 care. This has several implications. In the
absence of other factors, invasive cardiovascular monitoring will
prevent patients with epidural analgesia moving to a level 0 bed;
patients in level 0 beds are more likely to be mobile (e.g. to walk to
and from the toilet) than similar patients in level 2 care. Factors
influencing mobility will be discussed further. This study con-
firmed that a proportion of patients are well enough to step down
to the general ward environment within the first 24 h following
open liver resection. The necessity to manage patients with epi-








Contraindication to epidural WC:             7
Laparoscopic procedure:                         6
Resection with second procedure:           4
Body mass index > 50:                             1
Pre-existing condition limiting mobility:     1
Investigator unavailable:                          6
Other:                                                       190
Declined to participate (25)
No reason stated:              12
Did not want epidural:                               9









(One patient had a cardiac event
in the anaesthetic room
following induction of
anaesthesia and did not
proceed to surgery)
Figure 4 Flow diagram illustrating patient enrolment. WC, wound
catheter
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Table 1 Baseline characteristics and intraoperative details of patients undergoing open liver resection, randomized to either wound catheter
plus patient-controlled i.v. opiate analgesia (WI group) or epidural analgesia (EP group)
WI group EP group P-value
(n = 33) (n = 31)
Patient characteristics
Age, years, median (range) 60 (39–84) 60 (23–85) 0.877
Male gender, n (%) 17 (51.5) 19 (61.3) 0.431
BMI, median (range) 25 (19–36) 24 (18–33) 0.044
ASA physical status, n (%)
I 2 (6.1) 5 (16.1) 0.107
II 20 (60.5) 20 (64.5)
III 11 (33.3) 6 (19.4)
Indication for surgery, n (%)
Colorectal metastases 19 (57.6) 17 (54.8) 0.816
Cholangiocarcinoma 4 (12.1) 5 (16.1)
Hepatocellular carcinoma 2 (6.1) 3 (9.7)
Other malignancy 2 (6.1) 3 (9.7)
Benign disease 6 (18.2) 3 (9.7)
Previous laparotomy, n (%) 19 (57.6) 18 (58.1) 0.968
Intraoperative data
Operating time, min, median (range) 265 (50–550) 190 (90–540) 0.006
Extent of hepatic resection, n (%)
 3 segments 24 (72.7) 13 (41.9) 0.042
Section/segment/metastasectomy 7 (21.2) 15 (48.4)
Unresectable 2 (6.1) 3 (9.7)
Bile duct excision 9 (27.3) 8 (25.8) 0.894
Blood loss, ml, median (range) 870 (0–5000) 545 (150–2675) 0.106
Wound length, cm, median (range) 32.0 (23.0–53.0) 28.5 (16.0–35.0) <0.001
































































Figure 5 Mean pain scores (a) at rest (P = 0.015) and (b) on movement (P = 0.022) following open liver resection, in patients randomized to
either wound catheter patient-controlled i.v. opiate analgesia or epidural analgesia. PoD, postoperative day
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is therefore very likely to account for the difference demonstrated
between the groups in length of HDU stay. It may also account for
the difference in overall recovery time. Although a formal cost
analysis has not been performed, the practice of keeping patients
in the HDU environment simply for the delivery of epidural anal-
gesia also has resource and cost implications.
Analysis of pain scores demonstrated consistently better scores
in the EP group. Although pain at rest was scored as mild (score
range: 0–3) in both groups, it was rated as moderate (score range:
4–6) onmovement in theWI group. Improved dynamic pain relief
is a recognized advantage of epidural analgesia and intuitively
should allow for better mobilization following major surgery.
However, in this study, there was no difference between groups in
time to first mobilization. The WI group took statistically more
steps than the EP group in the first 48 h after surgery, but the
clinical significance of this is negligible. These findings are con-
sistent with those of Park et al., who found no difference in post-
operative physical activity scores between patients managed with
epidural and parenteral opioids, respectively, following major
abdominal surgery.3
It is likely that mobility in the early postoperative phase is
determined by factors other than adequate analgesia, including
the presence of lines and tubes, haemodynamic instability, patient
expectations, and cultural issues amongst medical and nursing
staff regarding the management of epidural analgesia. Although
a standardized care pathway outlined daily mobility targets, it
is possible that the single-blind design of this study may have
allowed the introduction of bias in terms of mobilization of
patients. However, if this is so, it simply highlights the need to find
a pragmatic approach to postoperative analgesia that works in the
real world outside the environment of the RCT.
The data regarding postoperative mobility are remarkable in
that the median number of steps taken within the first 48 h after
surgery was less than 10 in both groups. This demonstrates
the relative immobility of patients following major abdominal
surgery, even those who are managed within an enhanced recov-
ery programme that aims to pre-empt all of the issues limiting
mobility discussed herein. Further accurate investigation of post-
operative mobility using personal activity monitors is warranted
in patients undergoing major abdominal surgery.
There was no significant difference in complications
between the groups. The poorer dynamic pain relief associated
with wound infiltration plus PCA did not, therefore, equate to
delayed or complicated recovery in this study. This study, however,
was not powered to look at postoperative complications and thus,
although no major differences were seen, results must be inter-
preted with caution.
The study was of a single-blind design in an effort to reduce
bias in the measurement of pain scores. It was neither practical
nor safe for medical and nursing staff responsible for patient care
to be blinded to randomization. Although every effort was made
to maintain single blinding by avoiding discussion of analgesic
techniques within earshot of patients, this proved extremely dif-
ficult and was not universally successful. Whether this had any
influence on the pain scores recorded is unknown and it thus
remains a potential source of bias. The present authors would
counsel others who hope to conduct a study of this type against
attempting this type of blinding.
Nine patients declined to participate in the study because they
preferred not to receive epidural analgesia. Some had prior expe-
rience of epidural analgesia during previous surgery for primary
colorectal malignancy. Others had taken the opportunity to find
out more about epidurals in the weeks between being given infor-
mation about the study and presenting for operation. Ease of
access to information via the Internet means that patients are
becoming increasingly informed about the risks and benefits of
interventions such as epidural insertion. Conversely, four patients
declined to participate in the study as they preferred to receive
epidural analgesia postoperatively. This demonstrates that
patients are increasingly aware of, and expect to have, choices with
regard to analgesia.
As might be expected in a study of this size, there were no cases
of epidural haematoma or abscess formation. However, these
are recognized complications and whether or not patients are at
higher risk following liver resection because of potential coagul-
opathy remains to be determined.
To date, no other studies have compared epidural analgesia with
a multimodal analgesic regimen based around continuous local
anaesthetic wound infiltration. It is clear that the success of
enhanced recovery programmes depends on the combination of
many different elements, including optimized analgesia. Each
individual element must be investigated while the others are kept
constant and it should be recognized that different types of sur-
gical procedure may call for tailored protocols.
Continuous local anaesthetic wound infiltration, as part
of a multimodal analgesic regime, offers a clinically acceptable
alternative to epidural analgesia following open liver resection.
This approach has been shown to reduce the length of time
required to fulfil criteria for discharge from hospital. The cost
Table 2 Complication rates in patients undergoing open liver resec-
tion, randomized to either wound catheter plus patient-controlled i.v.
opiate analgesia (WI group) or epidural analgesia (EP group)
WI group EP group P-value
(n = 33) (n = 31)
Overall complication rate, n (%) 16 (48.5) 18 (58.1) 0.443
Highest grade of complication (Clavien–Dindo classification), n (%)
I 4 (12.1) 2 (6.5) 0.601
II 8 (24.2) 10 (32.3)
IIIa 2 (6.1) 3 (9.7)
IIIb 0 2 (6.5)
IVa 1 (3.0) 0
IVb 0 0
V 1 (3.0) 1 (3.2)
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of this reduction in time is poorer pain control within the
early postoperative period, but, in the present study, this did
not decrease mobility or overall outcome. When epidural
is contraindicated, technically impossible or refused by the
patient, an acceptable opiate-minimizing alternative has been
demonstrated.
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